Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 117.43 Billion | USD 182.17 Billion | 5.0% | 2023 |
The global Clinical Laboratory Tests Market Size accrued earnings worth approximately USD 117.43 Billion in 2023 and is predicted to gain revenue of about USD 182.17 Billion by 2032, is set to record a CAGR of nearly 5.0% over the period from 2024 to 2032.
Clinical laboratory tests are diagnostic techniques in the field of medicine that analyze samples of bodily fluids or tissues, such as blood, urine, or tissue, in order to detect and diagnose health issues, provide information for treatment choices, and monitor the advancement of diseases. These tests play a critical role in healthcare by serving as diagnostic tools for diseases, monitoring chronic disorders, assessing the efficacy of therapies, and conducting health screenings.
The clinical laboratory testing market is growing due to factors such as the aging population, the rising prevalence of target diseases, and the development of new solutions to meet the industry's increasing demand. We expect the rising incidence of conditions like cardiovascular diseases and diabetes to significantly contribute to the market's expansion in the projected timeframe.
The study includes drivers and restraints for the clinical laboratory tests market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the clinical laboratory tests market on a global as well as regional level.
One of the most notable trends in the global clinical laboratory services market is the increasing focus and efforts by major companies to build automated clinical labs. Due to increasing demand to reduce healthcare expenses over the past decade, laboratories have increasingly relied on the development of automated equipment to ensure profitability. Furthermore, lab automation offers benefits such as the substitution of laborious and repetitive work, a boost in throughput, and an enhancement in the quality of the outcomes. The anticipated benefits are likely to increase demand for lab automation and drive future market expansion.
Furthermore, numerous prominent organizations are prioritizing the introduction of cutting-edge diagnostic tests to enhance the reach of clinical laboratory services on a global scale. Therefore, the increasing technological improvements made by service providers and the launch of modern gadgets by key players are causing a significant increase in the acceptance of these services, which is driving the expansion of the market.
In order to give the users of this report a comprehensive view on the clinical laboratory tests market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, department, service provider, and region segment are benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the clinical laboratory tests market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the clinical laboratory tests market on global and regional basis.
Report Attributes | Report Details |
---|---|
Report Name | Clinical Laboratory Tests Market Research Report |
Market Size in 2023 | USD 117.43 Billion |
Market Forecast in 2032 | USD 182.17 Billion |
Growth Rate | CAGR of 5.0% |
Number of Pages | 211 |
Key Companies Covered | Quest Diagnostics, Inc., Abbott Laboratories, Inc., Siemens Healthineers, Inc., Sonic Healthcare Ltd., OPKO Health, Charles River Laboratories International, Inc., Laboratory Corporation of America, LLC, NeoGenomics Laboratories, Inc., Bioscientia Institut fr Medizinische Diagnostik GmbH, and Genoptix, Inc. among others. |
Segments Covered | By Product, By Department, By Service Provider, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Based on the conducted tests, we categorize the market into hematology, clinical chemistry, microbiology and cytology, genetic testing, and other types. In 2023, the clinical chemistry sector held the greatest market share in the clinical laboratory services market. Increased prevalence of diabetes, thyroid, and hormonal problems, along with the availability of at-home clinical lab testing services, have contributed to this category's growth. A rising number of biochemistry test procedures is likely to drive the category's growth.
We categorize the global market based on age into two groups: adult and pediatric. In 2023, the adult segment dominated the global market with the largest share. The increase in the senior population worldwide, who are experiencing chronic illnesses, is the main reason for the expansion of this market. We anticipate that adults' increasing use of sophisticated clinical laboratory tests will propel this category's expansion even further.
Based on the source of payment, we categorize the market into private, public, and out-of-pocket. In 2023, the public category had the largest market share. We anticipate that the government's rising healthcare expenditure and the enhancement of reimbursement rules will drive growth in this segment throughout the projected period.
We categorize the global market for service providers into stand-alone laboratories, clinic-based laboratories, hospital-based laboratories, and other types. In 2023, the hospital-based laboratories segment had the largest market share. The segment's expansion is due to the growing number of hospital laboratories, technological advancements in automated clinic laboratories, an increase in patient visits for testing, and a growing demand for clinical laboratory services.
Regional Analysis
In 2023, the North American market, with a value over USD 100 billion, held the largest share of the global market. The significant healthcare expenditure and increasing demand for clinical laboratory testing for routine health check-ups and chronic conditions like cancer, arthritis, and heart illnesses primarily contribute to the region's dominance. Sophisticated technologies like big data engines and artificial intelligence (AI) are driving the regional market expansion by facilitating quick diagnosis.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Some of the leading players in the global market include
By Product Analysis
By Department Analysis
By Service Provider Analysis
By Region Analysis
FrequentlyAsked Questions
Increasing awareness among healthcare professionals and patients about the need for routine body profiling globally is expected to increase demand for clinical laboratory tests.
According to the report, Global Clinical Laboratory Tests market size earned around $117.43 Bn in 2023 and is expected to reach $182.17 Bn by 2032, with a projected CAGR of 5.0%.
Asia Pacific is likely to be the fastest-growing market in the forecast period due to improved healthcare infrastructure supporting the introduction of advanced diagnostic technologies in China and India's emerging markets. In addition, the existence of untapped opportunities in the form of unmet medical needs, optimistic economic growth and growing avenues of scientific research are among the primary drivers for clinical laboratory testing on the Asia Pacific market.
key players of clinical laboratory tests market are Quest Diagnostics, Inc., Abbott Laboratories, Inc., Siemens Healthineers, Inc., Sonic Healthcare Ltd., OPKO Health, Charles River Laboratories International, Inc., Laboratory Corporation of America, LLC, NeoGenomics Laboratories, Inc., Bioscientia Institut fr Medizinische Diagnostik GmbH, and Genoptix, Inc. among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed